SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008120
Filing Date
2022-05-10
Accepted
2022-05-10 16:24:36
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20220331x10q.htm   iXBRL 10-Q 1065207
2 EX-10.1 omer-20220331xex10d1.htm EX-10.1 43372
3 EX-31.1 omer-20220331xex31d1.htm EX-31.1 11026
4 EX-31.2 omer-20220331xex31d2.htm EX-31.2 12229
5 EX-32.1 omer-20220331xex32d1.htm EX-32.1 8171
6 EX-32.2 omer-20220331xex32d2.htm EX-32.2 7724
7 GRAPHIC omer-20220331xex10d1001.jpg GRAPHIC 58156
  Complete submission text file 0001558370-22-008120.txt   5692245

Data Files

Seq Description Document Type Size
8 EX-101.SCH omer-20220331.xsd EX-101.SCH 42776
9 EX-101.CAL omer-20220331_cal.xml EX-101.CAL 52454
10 EX-101.DEF omer-20220331_def.xml EX-101.DEF 167291
11 EX-101.LAB omer-20220331_lab.xml EX-101.LAB 388533
12 EX-101.PRE omer-20220331_pre.xml EX-101.PRE 311132
64 EXTRACTED XBRL INSTANCE DOCUMENT omer-20220331x10q_htm.xml XML 968492
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 22910087
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences